Caption Management, LLC Rigel Pharmaceuticals Inc Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $330,980 - $1.58 Million	494,000 New	494,000 $558,000
Q1 2022 May 13, 2022	SELL	$2.22 - $3.45 $305,250 - $474,375	-137,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.36 - $3.57 $5,900 - $8,925	2,500 Added 1.85%	137,500 $364,000
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $306,250 - $393,750	-87,500 Reduced 39.33%	135,000 $490,000
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $610,275 - $896,650	197,500 Added 790.0%	222,500 $966,000
Q1 2021 May 17, 2021	SELL	$3.35 - $4.93 $150,750 - $221,850	-45,000 Reduced 64.29%	25,000 $86,000
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $124,600 - $289,100	70,000 New	70,000 $168,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.